Whats new?
Download app
Access BlinkX everywhere across devices
Our updates are just like your noodles. Instant. You want?
Notifications can be turned off anytime from browser settings
Our updates are just like your noodles. Instant. You want?
Notifications can be turned off anytime from browser settings
*All values are in Rs. Cr
| (Rs. CR) | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|
| Revenue | 12.74 | 9.04 | 11.58 |
| Operating Expense | 6.33 | 4.27 | 6.98 |
| Net Profit | 1.32 | 0.25 | 0.26 |
| Net Profit Margin | 10.36 | 2.77 | 2.25 |
| Earning Per Share | 0.89 | 0.16 | 0.17 |
| EBIDTA | 6.42 | 4.82 | 4.67 |
| Effective Tax Rate | 9.36 | 3.77 | 3.7 |
(Rs. Cr)
Revenue
Operating Expense
Net Profit
Net Profit Margin
Earning Per Share
EBIDTA
Effective Tax Rate
Dec 2023
12.74
6.33
1.32
10.36
0.89
6.42
9.36
Sep 2023
9.04
4.27
0.25
2.77
0.16
4.82
3.77
Jun 2023
11.58
6.98
0.26
2.25
0.17
4.67
3.7
*All values are in Rs. Cr
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Total Revenue Annual | 52.23 | 51.39 | 51.78 |
| Operating Expenses Annual | 30.73 | 35.58 | 34.11 |
| Operating Profit Annual | 21.54 | 15.91 | 17.74 |
| Interest Annual | 7.65 | 3.99 | 3.53 |
| Depreciation | 9.27 | 7.45 | 5.59 |
| Net Profit Annual | 2.65 | 2.2 | 5.68 |
| Tax Annual | 1.97 | 2.27 | 2.94 |
Particulars
Total Revenue Annual
Operating Expenses Annual
Operating Profit Annual
Interest Annual
Depreciation
Net Profit Annual
Tax Annual
Mar 2023
52.23
30.73
21.54
7.65
9.27
2.65
1.97
Mar 2022
51.39
35.58
15.91
3.99
7.45
2.2
2.27
Mar 2021
51.78
34.11
17.74
3.53
5.59
5.68
2.94
*All values are in Rs. Cr
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Cash Flow at the Beginning | 1.71 | 1.17 | 1.03 |
| Cash Flow from Operations | 14.83 | 16.64 | 14.18 |
| Cash Flow from Investing | -4 | -51.11 | -22.82 |
| Cash Flow from Financing | -11.18 | 35.02 | 8.78 |
| Cash Flow at the End | 1.37 | 1.71 | 1.17 |
Particulars
Cash Flow at the Beginning
Cash Flow from Operations
Cash Flow from Investing
Cash Flow from Financing
Cash Flow at the End
Mar 2023
1.71
14.83
-4
-11.18
1.37
Mar 2022
1.17
16.64
-51.11
35.02
1.71
Mar 2021
1.03
14.18
-22.82
8.78
1.17
*All values are in Rs. Cr
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| PBDIT Margin (%) | 41.89 | 31.5 | 34.53 |
| PBIT Margin (%) | 24.14 | 17.01 | 23.74 |
| PBT Margin (%) | 21.08 | 13.02 | 17.27 |
| Net PROFIT Margin (%) | 5.09 | 4.28 | 10.97 |
| Return On Networth / Equity (%) | 5.35 | 4.91 | 15.03 |
| Return On Networth /Employed(%) | 10.97 | 9.25 | 18.65 |
| Return On Assets (%) | 2.29 | 2.31 | 8.67 |
| Total Debt / Equity(X) | 1.27 | 1.05 | 0.67 |
| Asset Turnover Ratio (%) | 0.45 | 0.54 | 0.79 |
Particulars
PBDIT Margin (%)
PBIT Margin (%)
PBT Margin (%)
Net PROFIT Margin (%)
Return On Networth / Equity (%)
Return On Networth / Employed(%)
Return On Assets (%)
Total Debt / Equity(X)
Asset Turnover Ratio (%)
Mar 2023
41.89
24.14
21.08
5.09
5.35
10.97
2.29
1.27
0.45
Mar 2022
31.5
17.01
13.02
4.28
4.91
9.25
2.31
1.05
0.54
Mar 2021
34.53
23.74
17.27
10.97
15.03
18.65
8.67
0.67
0.79
*All values are in Rs. Cr
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Fixed Assets Annual | 88.87 | 95.17 | 52.05 |
| Total Current Assets Annual | 31.79 | 26.03 | 27.09 |
| Non Current Assets Annual | 91.24 | 96.45 | 52.44 |
| Total Shareholders Funds Annual | 51.87 | 47.13 | 42.53 |
| Total Assets Annual | 123.03 | 122.49 | 79.52 |
Particulars
Fixed Assets Annual
Total Current Assets Annual
Non Current Assets Annual
Total Shareholders Funds Annual
Total Assets Annual
Mar 2023
88.87
31.79
91.24
51.87
123.03
Mar 2022
95.17
26.03
96.45
47.13
122.49
Mar 2021
52.05
27.09
52.44
42.53
79.52
As of May 20, 2024, Vivo Bio Tech Ltd has a market capitalization of 28.76 Cr. Value Research classifies it as a Micro-Cap company.
No, Vivo Bio Tech Ltd is not debt-free with a debt-to-equity ratio of 1.20.
In FY 2023, Vivo Bio Tech Ltd recorded a total revenue of approximately 52.23 Cr marking a significant milestone in the company's financial performance.
Vivo Bio Tech Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.4% and 0.0% annually, respectively..
Vivo Bio Tech Ltd's current PE ratio is 10.85.
Vivo Bio Tech Ltd's ROCE averaged 11.6% from the FY ending March 2021 to 2023, with a median of 10.7%. It peaked at 16.5% in March 2021, reflecting strong capital efficiency over the period..
Vivo Bio Tech Ltd's latest EBIT is Rs. 12.27 Cr, surpassing the average EBIT of Rs. 10.96 Cr over the 5 years..